Jabalpur: Doctors perform a Diagnostic Nasal Endoscopy (DNE) on a patient to detect Black Fungus at NSCB medical college and hospital in Jabalpur, Thursday, May 20, 2021. (PTI Photo) (PTI05_20_2021_000153A) | Photo Credit: -
MSN Laboratories Pvt Ltd on Friday launched Posaconazole in the domestic market to treat black fungus. The Hyderabad-based company has launched the product under the brand name, PosaOne as 100 mg Delayed Release tablets and 300 mg injections, respectively.
Posaconazole is a triazole antifungal agent indicated for treating mucormycosis or or black fungus. Many patients recovering from Covid-19 have been detected with the rare and deadly fungal infection . With mortality rates on the incline, an anti-fungal medication is of urgent need.
“MSN has developed the active pharmaceutical ingredient and the formulation of PosaOne in its in-house R&D and manufacturing units. The drug is approved by the Drug Controller General of India (DGCI) and matches the International quality standards,” the company said in a release.
Published on May 21, 2021
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.